Drug comparisons
Saxagliptin vs Glyburide
Compare Saxagliptin and Glyburide for type 2 diabetes. DPP-4 inhibitor Saxagliptin offers lower hypoglycemia risk than the sulfonylurea Glyburide.
No comparison dimensions are available for this page.
Clinical context
This comparison typically arises when evaluating a switch from a sulfonylurea like Glyburide to a modern DPP-4 inhibitor for safer type 2 diabetes control.
Bottom line
Saxagliptin is generally preferred over Glyburide in current practice due to its better safety profile and lower hypoglycemia risk.
All medication comparisons